Cargando…

A Genome-Wide Screen for the Exonisation of Reference SINE-VNTR-Alus and Their Expression in CNS Tissues of Individuals with Amyotrophic Lateral Sclerosis

The hominid-specific retrotransposon SINE-VNTR-Alu (SVA) is a composite element that has contributed to the genetic variation between individuals and influenced genomic structure and function. SVAs are involved in modulating gene expression and splicing patterns, altering mRNA levels and sequences,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfaff, Abigail L., Bubb, Vivien J., Quinn, John P., Koks, Sulev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380656/ https://www.ncbi.nlm.nih.gov/pubmed/37511314 http://dx.doi.org/10.3390/ijms241411548

Ejemplares similares

Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus
por: Fröhlich, Alexander, et al.
Publicado: (2022)

Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
por: Pfaff, Abigail L., et al.
Publicado: (2022)

CRISPR deletion of a SINE-VNTR-Alu (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the MAPT locus
por: Fröhlich, Alexander, et al.
Publicado: (2023)

The Role of SINE-VNTR-Alu (SVA) Retrotransposons in Shaping the Human Genome
por: Gianfrancesco, Olympia, et al.
Publicado: (2019)

Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
por: Pfaff, Abigail L., et al.
Publicado: (2021)

Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
por: Fröhlich, Alexander, et al.
Publicado: (2023)

A polymorphic transcriptional regulatory domain in the amyotrophic lateral sclerosis risk gene CFAP410 correlates with differential isoform expression
por: Marshall, Jack N. G., et al.
Publicado: (2022)

A SINE-VNTR-Alu in the LRIG2 Promoter Is Associated with Gene Expression at the Locus
por: Hall, Ashley, et al.
Publicado: (2020)

Frequency and methylation status of selected retrotransposition competent L1 loci in amyotrophic lateral sclerosis
por: Savage, Abigail L., et al.
Publicado: (2020)

An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
por: Pfaff, Abigail L., et al.
Publicado: (2020)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
por: Koks, Sulev, et al.
Publicado: (2021)

Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome
por: Koks, Sulev, et al.
Publicado: (2021)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Alusión, referencialidad, intertextualidad
por: Beristáin, Helena, 1927-

Variable number tandem repeats – Their emerging role in sickness and health
por: Marshall, Jack NG, et al.
Publicado: (2021)

Intronic Alus Influence Alternative Splicing
por: Lev-Maor, Galit, et al.
Publicado: (2008)

Bit slice design: controllers and ALUs
por: White, Donnamaie E
Publicado: (1981)

Intergenic Alu exonisation facilitates the evolution of tissue-specific transcript ends
por: Tajnik, Mojca, et al.
Publicado: (2015)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
por: Tefera, Tesfaye Wolde, et al.
Publicado: (2021)

Insertion and deletion polymorphisms of the ancient AluS family in the human genome
por: Kryatova, Maria S., et al.
Publicado: (2017)

CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
por: Evans, Matthew C, et al.
Publicado: (2014)

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
por: Steinruecke, Moritz, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
por: Forsberg, Karin M., et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis
por: Usarek, Ewa, et al.
Publicado: (2017)

Telehealth for amyotrophic lateral sclerosis in a multidisciplinary service in a Brazilian reference center
por: Fidelix, Emanuela Coriolano, et al.
Publicado: (2023)

Clinical Psychology and Amyotrophic Lateral Sclerosis
por: Pagnini, Francesco, et al.
Publicado: (2010)

Glial Cells in Amyotrophic Lateral Sclerosis
por: Lasiene, Jurate, et al.
Publicado: (2011)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Redox Regulation in Amyotrophic Lateral Sclerosis
por: Parakh, Sonam, et al.
Publicado: (2013)

Genetics of amyotrophic lateral sclerosis: an update
por: Chen, Sheng, et al.
Publicado: (2013)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Risk factors for amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2qj4qe9v54ho2o42fo86sabutg